family med practice essentials Flashcards
prostate cancer screening
aafp and uspstf recommends that digital rectum exam and PSA screening be individual decision; they recommend against screening in pts >70
criteria for diabetes
6.5 A1c; 126 fasting glucose, 200 random glucose plus symptoms of hyperglycemia (polydipsia, polyuria, weight loss), OR 200glucose 2h after oral glucose tolerance test X2
criteria for prediabetes
5.7-6.4 A1c; fasting glucose 100-125; 2 h prandial glc 140-199
prevention of diabetes
- loss of 7-10% of body weight
- 150min activity/week
- technology assisted interventions
- metformin for prediabetes especially if BMI>35, less than 60, and if woman with hx gestational diabetes
- be careful bc longterm metformin use can lead to B12 deficiency! monitor B12 esp if anemia or peripheral neuropathy
screening for CVD recommended in pts with prediabetes
screening for CVD recommended in pts with prediabetes
people 2-64 with diabetes should receive which vaccines?
flu,
PPSV23 pneumococcal (higher risk of bacterial pneumonia and higher mortality rate!)
people with diabetes 18-59 should also get Hep B if they havent already gotten it
comprehensive physical exam for diabetics
height, weight BMI
BP, orthostatics if indicated
fundoscopic
thyroid palpation
skin (look for acanthosis nigricans, insulin injection site , lipodystrophy)
comprehensive foot exam : look for callus, skin integrity, foot deformity, ulcer, toenails, pedal pulses– refer for ABI if diminished, temp/vibration or pinprick sensation; 10g monofilament exam
what labs do you get for diabetics?
A1c lipid panel (LDL, HDL, triglycerides, total cholesterol) liver function tests spot urinary creatinine to alubumin ratio (detect small amount of protein in urine --> kidney damage) serum Cr, estimated GFR TSH if DM1 B12 if on metformin [K+] if on ARBs, ACEi, diuretics
how often should you test A1c in DM pts who are meeting treatment goals and have stable glycemic control?
2x/year
how often should you test A1c in DM pt who have unstable glycemic control or who’s tx has changed
4x/year
remember A1c is not a perfect measure of glycemic control, isn’t going to show big deviations so you might want to monitor in other ways
A1c goals for nonpregnant adults
usually <7%
you can shoot for lower if you want and not big risk of hypoglycemia
if history of severe hypoglycemia, limited life expectancy, advanced microvascular or macrovascular complications, extensive comorbid conditions, or long-standing diabetes in whom the goal is difficult to achieve despite diabetes self-management education, appropriate glucose monitoring, and effective doses of multiple glucose-lowering agents including insulin, then it might be appropriate to shoot for <8%
A1c goals for ppl with shortened life expectancy, hx of severe hypoglycemia, advanced vascular complications, extensive comorbid conditions, longstandind DM where its been really hard to reach goal
<8%
hypoglycemia 1 range
<70
>54
hypoglycemia 2
<54
hypoglycemia 3
altered mental status
sx of hypoglycemia
Symptoms of hypoglycemia include, but are not limited to, shakiness, irritability, confusion, tachycardia, and hunger. Hypoglycemia may be inconvenient or frightening to patients with diabetes. Level 3 hypoglycemia may be recognized or unrecognized and can progress to loss of consciousness, seizure, coma, or death. It is reversed by administration of rapid-acting glucose or glucagon.
cognitive damage
The use of glucagon is indicated for the treatment of hypoglycemia in people unable or unwilling to consume carbohydrates by mouth. Those in close contact with, or having custodial care of, people with hypoglycemia-prone diabetes (family members, roommates, school personnel, childcare providers, correctional institution staff, or coworkers) should be instructed on the use of glucagon, including where the glucagon product is kept and when and how to administer. An individual does not need to be a health care professional to safely administer glucagon. In addition to traditional glucagon injection powder that requires reconstitution prior to injection, intranasal glucagon and glucagon solution for subcutaneous injection recently received U.S. Food and Drug Administration approval. Care should be taken to ensure that glucagon products are not expired.
hypoglycemia unawareness
deficient counterregulatory hormone release, especially in older adults, and a diminished autonomic response
you can break the cycle by loosening glycemic control for a few weeks
recommended weightloss goal for obese DM pts
5+% of body weight (and maintain it)
ADA recommends high intensity interventions (≥16 sessions in 6 months) and focus on dietary changes, physical activity, and behavioral strategies to achieve a 500–750 kcal/day energy deficit
For patients who achieve short-term weight-loss goals, long-term (≥1 year) weight maintenance programs are recommended when available. Such programs should at minimum provide monthly contact, as well as encourage ongoing monitoring of body weight (weekly or more frequently) and other self-monitoring strategies, including high levels of physical activity (200–300 min/week)
phentermine
short term (less than 12 wks) weight loss increases BP don't use with MAOIs, (linezolid abx has maoi activity)
Orlistat
lipase inhibitor for long term weight loss
can cause malabsorption of fat soluble vitamins. in rare cases can cause liver damage. Side effects include kidney and gall stones, GI distress, headache, back pain
Lorcaserin
for longterm weight loss
Selective serotonin receptor agonist
increases BP! monitor for suicidal ideation , depression, liver and renal failure; theoretically could cause serotonergic syndrome like or neuroleptic malignant like issues if combined with other sertonergic/antidopaminergic agents
phertermine/topiramate combo
for longterm weight loss
teratogen!! increased BP! cognitive impairment, insomnia, acute angle closure glaucoma
naltrexone/bupropion
opioid antagonist/antidepressant combo for long term weight loss
BLACK BOX: SUICIDAL IDEATION
not for seizure pts!! not with opioid therapy; acute angle closure glaucoma
liraglutide
glucagon like peptide 1 receptor agonist for longterm weight loss
lots of GI side effects!
acute pancreatitis?, potential kidney injury
BLACK BOX: c cell thyroid cancer
preferred initial pharmacologic agent for the treatment of type 2 diabetes.
metformin
monitor B12
renal clearance; GFR>30
metformin has weight loss and cvd benefits
GFR for metformin
30
if A1c > 1.5-2% above goal, you start initial treatment on metformin combined with ______ according to VERIFY trial
vildagliptin
DPP-4 inhibitor
what should you add to metformin when you need to step up for a DM pt with ASCVD, ASCVD risk?
liraglutide semaglutide albigultide dulaglutide (all glucagon like peptide 1 receptor agonists)
what should you add to metformin when you need to step up for a DM pt with HF or kidney disease?
canagliflozin
dapagliflozin
empagliflozin
ertugliflozin
(risk of UTIs)
what should you add to metformin when you need to minimize weight gain or promote weight loss?
GLP1ras: dulaglutide, liraglutide, exanatide, semaglutide, lixisenitide
SGLT2I (sodium glucose cotransporter 2 inhibitor)
dapagliflozin
JNC 8 cutoff for HTN tx
140/80
or 150/90 if >60 yo
initial tx for HTN
ARB, ACEi, thiazide or calcium channel blocker
initial tx for HTN in black pts
thiazide or calcium channel blocker
name 3 ca channel blockers
nifidepine
amlodipine
diltiazam
name side effects of calcium channel side effects
flushing, peripheral edema, reflex tachycardia, headaches, dizziness, worsened angina, gingival hyperplasia